» Articles » PMID: 26092490

Clinical, Etiological and Therapeutic Aspects of Cerebral Folate Deficiency

Overview
Specialties Neurology
Pharmacology
Date 2015 Jun 21
PMID 26092490
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral folate deficiency is defined as any neurological condition associated with low cerebrospinal fluid folate concentrations. It is becoming increasingly associated with several neurological diseases, either genetic or environmental. Treatment of cerebral folate deficiency by folate supplementation is generally effective, improving the neurological outcome of some patients. However, to treat cerebral folate deficiency, the proper choice of one of the available folate forms is essential. The distinct brain folate metabolism features compared with peripheral folate metabolic pathways strongly suggest the investigation of different folate forms, such as the biologically active folinic acid and 5-methyltetrahydrofolate, since they are efficiently transported to the brain. Regarding the oral doses of the different folate forms, despite the fact that there are some recommendations, there is no general consensus. Further investigation and designing clinical trials are advisable to elucidate these aspects.

Citing Articles

Cerebral Folate Transport Deficiency in 2 Cases with Intractable Myoclonic Epilepsy.

Girgis M, Mahfouz E, Abdellatif A, Taha F, ElNaggar W J Epilepsy Res. 2024; 14(1):29-36.

PMID: 38978529 PMC: 11227922. DOI: 10.14581/jer.24005.


Gene Variation With Adult-Onset Cerebral Folate Deficiency and Stable Clinical and MRI Features up to 2 Years.

Manco C, Cortese R, Alberti M, Bianchi S, Monti L, De Stefano N Neurol Genet. 2024; 9(6):e200104.

PMID: 38239817 PMC: 10629229. DOI: 10.1212/NXG.0000000000200104.


Variants May Contribute to the Pathophysiology of Human Cerebral Folate Deficiency.

Han X, Cao X, Cabrera R, Ramirez P, Zhang C, Ramaekers V Biology (Basel). 2023; 12(1).

PMID: 36671766 PMC: 9855468. DOI: 10.3390/biology12010074.


Metabolomic disorders: confirmed presence of potentially treatable abnormalities in patients with treatment refractory depression and suicidal behavior.

Pan L, Segreti A, Wrobleski J, Shaw A, Hyland K, Hughes M Psychol Med. 2022; 53(13):6046-6054.

PMID: 36330595 PMC: 10520591. DOI: 10.1017/S0033291722003233.


Dihydropyridine Reductase Deficiency: Acute Encephalopathy Related to Folinic Acid Treatment Interruption in a Girl.

Pappalardo M, Di Nora A, Giugno A, Meli C, Sapuppo A, Pavone P Glob Med Genet. 2022; 9(3):247-251.

PMID: 36132999 PMC: 9484871. DOI: 10.1055/s-0042-1756661.